The global microRNA market was valued at $1.61 billion in 2023 and is projected to reach $6.11 billion by 2034, growing at a compound annual growth rate (CAGR) of 12.89% from 2024 to 2034. The increasing prevalence of chronic conditions, along with advancements in biotechnology, are key factors driving the market’s growth.
Download a sample of this report @ https://www.towardshealthcare.com/personalized-scope/5211
MicroRNAs (miRNAs) are small, non-coding RNA molecules that regulate gene expression. In the biotechnology and life sciences industries, they are critical for developing diagnostic tools and therapies. miRNAs play a vital role in controlling gene expression involved in numerous illnesses, including cancer and infectious diseases. As biomarkers, microRNAs help identify the diagnostic, prognostic, and predictive values for patient management and are pivotal in the detection of diseases in tissues and bodily fluids.
Artificial Intelligence (AI) and machine learning are revolutionizing the microRNA market by improving the discovery and development of miRNA-based therapies. Machine learning techniques help identify new miRNA biomarkers and build high-performance classification models for disease detection, such as cancer. For instance, in July 2023, researchers developed a multiclass cancer detection tool using AI and microRNA, enhancing non-invasive diagnostic methods.
Leading companies in the microRNA market include:
Research into miRNAs as therapeutic targets has led to numerous clinical trials worldwide. A search of the Clinical Trials Database in January 2023 revealed 1,213 studies related to microRNA:
These clinical trials aim to explore miRNA’s potential in drug development, diagnosis, and screening across various human disorders.
Discover our detailed Table of Contents (TOC) for the Industry, providing a thorough examination of market segments, material, emerging technologies and key trends. Our TOC offers a structured analysis of market dynamics, emerging innovations, and regional dynamics to guide your strategic decisions in this rapidly evolving healthcare field – https://www.towardshealthcare.com/table-of-content/microrna-market-sizing
To own our research study instantly, Click here @ https://www.towardshealthcare.com/price/5211
You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com
About Us
Towards Healthcare is a leading global provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations. We are a global strategy consulting firm that assists business leaders in gaining a competitive edge and accelerating growth. We are a provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations.
Explore the comprehensive statistics and insights on healthcare industry data and its associated segmentation: Get a Subscription
For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare
The global pharma CRO services market is on a solid growth path. It’s expected to jump from USD 36.66 billion… Read More
The use of Artificial Intelligence (AI) in mental health care is growing fast. In 2024, this market was worth about… Read More
The global cancer vaccines market is on a strong growth path. It's expected to expand from $11.38 billion in 2025… Read More
The global bioprocess containers market is on a major growth path. Valued at around $3.12 billion in 2024, it’s expected… Read More
The world is moving towards personalized healthcare, and patient-centric apps are at the forefront of this shift. In 2024, the… Read More
📊 Market Snapshot The global flow cytometry services market is witnessing impressive growth. It was valued at USD 3.37 billion… Read More